Remove 2014 Remove Healthcare Remove Pharma
article thumbnail

American healthcare is unsustainable

World of DTC Marketing

In Gallup’s 2019 survey of potentially worrisome issues among Americans, healthcare topped the list for the fifth straight year. The health insurance, PBM’s, and big pharma didn’t accumulate their massive wealth by running deficits. In addition, hospital care accounts for 33% of the nation’s healthcare costs.

article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. It also raises healthcare costs for public and private insurers alike. Of course, the drug industry warns that any price negotiation will kill innovation.

Pharma 255
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. ” Pharma CEOs are compensated on how their products earn money.

Pharma 210
article thumbnail

The financial toxicity of treating cancer

World of DTC Marketing

In 2014, cancer patients paid $4 billion out-of-pocket for cancer treatment. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Insurance 273
article thumbnail

Norstella, Citeline merge to create $5bn pharma tech firm

pharmaphorum

Citeline provides intelligence, data and software for clinical trials, development and regulatory compliance and was formerly part of Informa was called Pharma Intelligence ahead of a rebranding earlier this year. The post Norstella, Citeline merge to create $5bn pharma tech firm appeared first on.

Pharma 101
article thumbnail

Preparing for a new era in the rare disease sector

European Pharmaceutical Review

For documents published in 2014 this number was just six; in 2024 it was 157 ( Figure 2 ). 2014-2024 (Credit: Elsevier BV – Scopus) Figure 2 : Documents by year. 2014-2024 (Credit: Elsevier BV – Scopus) Regionally, the US is dominating rare disease research. What solutions should pharma professionals focus on?

article thumbnail

Developing an effective contamination control strategy

European Pharmaceutical Review

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Early adopters started putting these strategies together around 20 years ago.